All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • TQA2225AP025Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Non-alcoholic Steatohepatitis

  • TQA3334Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Chronic Hepatitis B

  • TQB3126Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Breast Cancer

  • TQB3201Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Metastatic Castration-resistant Prostate Cancer

  • TQB3617Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Myelofibrosis

  • TQC3721Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Pulmonary Disease, Chronic Obstructive

  • TQD3524Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

  • TRA16Phase 21 trial

    Wuhan Kangfude Urolithiasis Research Institute Co., Ltd. · Enteric Hyperoxaluria

  • TRCN-1023Phase 21 trial

    Trace Neuroscience, Inc. · Amyotrophic Lateral Sclerosis

  • TrevogrumabREGN1033, GDF8Phase 21 trial

    Regeneron · Obesity

  • TRG-200Phase 21 trial

    Trigone Pharma Ltd. · Overactive Bladder (OAB)

  • TRI-611Phase 21 trial

    TRIANA Biomedicines, Inc. · ALK-positive NSCLC, ALK-Positive Lung Cancer, ALK-positive Non-small Cell Lung Cancer

  • TRIV-509Phase 21 trial

    Triveni Bio · Atopic Dermatitis

  • TRIV-573Phase 21 trial

    Triveni Bio · Atopic Dermatitis

  • TrizepatidePhase 21 trial

    Novo Nordisk · Diabetes Mellitus, Type 2

  • TRL1068Phase 21 trial

    Trellis Bioscience LLC · Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee

  • TRTL-913Phase 21 trial

    Tortugas Neuroscience, Inc. · Tinnitus

  • TRTP-101Phase 21 trial

    CellinCells · Atrophic Scar

  • TRX103Phase 21 trial

    Tr1X, Inc. · Crohns Disease

  • TRX319Phase 21 trial

    Tr1X, Inc. · Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis (SPMS), Multiple Sclerosis

  • TRYP-0082Phase 21 trial

    TRYP Therapeutics · Irritable Bowel Syndrome

  • TSRA-196Phase 21 trial

    Tessera Therapeutics, Inc. · Alpha-1 Antitrypsin Deficiency (AATD)

  • TST003Phase 21 trial

    Transcenta Therapeutics (Hangzhou) Co., Ltd. · Locally Advanced Solid Tumor, Metastatic Tumor, Colorectal Adenocarcinoma

  • TT-01488Phase 21 trial

    TransThera Sciences (Nanjing), Inc. · Mantle Cell Lymphoma (MCL)

  • TT-10Phase 21 trial

    Portage Biotech · Renal Cell Cancer, Castrate Resistant Prostate Cancer, Non Small Cell Lung Cancer

  • TTYP01Phase 21 trial

    Shanghai Auzone Biological Technology Co., Ltd. · Autism Spectrum Disorder (ASD)

  • TU-100Phase 21 trial

    Tsumura USA · Delay in GI Recovery/Postoperative Ileus (POI)

  • TUB-030Phase 21 trial

    Gilead Sciences · Advanced Solid Tumors, HNSCC, SCLC

  • TuspetinibHM43239Phase 21 trial

    Aptose Biosciences Inc. · Leukemia, Myeloid, Acute, Refractory AML, Relapsed Adult AML

  • TXN10128Phase 21 trial

    Txinno Bioscience Inc. · NSCLC (Non-small Cell Lung Cancer)

  • TY-302Phase 21 trial

    TYK Medicines, Inc · Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • TYK-01054Phase 21 trial

    TYK Medicines, Inc · Solid Tumor Malignancies, Malignant Mesothelioma (MM)

  • U16Phase 21 trial

    Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · Relapsed or Refractory Non-Hodgkin's Lymphoma

  • UB-421Phase 21 trial

    UBP Greater China (Shanghai) Co., Ltd · HIV-1-infection

  • UCART20x22Phase 21 trial

    Cellectis S.A. · B-cell Non-Hodgkin Lymphoma (B-NHL)

  • UCART22Phase 21 trial

    Cellectis S.A. · B-cell Acute Lymphoblastic Leukemia

  • UCB0022Phase 21 trial

    UCB · Parkinson Disease

  • UCB1381Phase 21 trial

    UCB · Atopic Dermatitis

  • UI-102Phase 21 trial

    United Immunity, co., Ltd. · Advanced Cancer

  • UKK-0018Phase 21 trial

    Ukko Inc · Peanut-Induced Anaphylaxis, Peanut Allergy

  • UnasnemabMT-3921Phase 21 trial

    Tanabe Pharma America, Inc. · Spinal Cord Injury

  • UX016Phase 21 trial

    Ultragenyx Pharmaceutical Inc · GNE Myopathy

  • VAL-083Phase 21 trial

    Kintara Therapeutics, Inc. · Glioma, Glioblastoma, Glioblastoma Multiforme

  • ValaciclovirPhase 21 trial

    Trogenix ltd · Glioblastoma (GBM), High Grade Gliomas, Recurrent Glioblastoma

  • VAX-24Phase 21 trial

    Vaxcyte, Inc. · Pneumococcal Vaccines

  • VB15010Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Cancer, Neoplasms, Neoplasms, Breast

  • VB19055Phase 21 trial

    Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · Hypertension, Resistant Hypertension, Uncontrolled Hypertension

  • VBC101Phase 21 trial

    VelaVigo Bio Inc · Participants With Advanced Solid Tumor Malignancies

  • VBC103Phase 21 trial

    VelaVigo Bio Inc · Participants With Advanced Solid Tumor Malignancies

  • VBC106Phase 21 trial

    VelaVigo Bio Inc · Participants With Advanced Solid Tumor Malignancies

NewerPage 72 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.